The antihyperlipidemic drugs market is expected to be shaped by continued efforts to manage elevated cholesterol and reduce cardiovascular risk. Statins remain an established treatment option, while newer therapies provide alternatives for patients who need additional lipid control. Greater awareness, earlier diagnosis, and improved treatment guidelines may influence prescribing patterns....
